| Clostridiales bacterium Sjm18-20| DSM 18026| NBRC 101213| Oscillibacter valericigenes| Oscillibacter valericigenes Iino et al. 2007 emend. Le Roy et al.| strain Sjm18-20
Gut Microbiota: Oscillibacter species are part of the human gut microbiota, which is a complex community of microorganisms residing in the gastrointestinal tract. The gut microbiota plays a crucial role in various physiological processes, including digestion, nutrient absorption, and immune system modulation.
Fermentation and Short-Chain Fatty Acids (SCFAs): Bacteria, including Oscillibacter valericigenes, are involved in the fermentation of dietary fibers in the colon. This process produces short-chain fatty acids (SCFAs), such as valeric acid. SCFAs are known to have various effects on gut health and overall well-being.
Valeric Acid Production: Valeric acid is a specific SCFA produced by certain bacteria in the gut during the fermentation of dietary fibers. While some studies suggest that SCFAs, including valeric acid, may have beneficial effects on gut health, immune function, and metabolic processes, the specific impacts of Oscillibacter valericigenes and valeric acid production may vary.
Potential Health Effects: Research on the health impacts of Oscillibacter valericigenes specifically is limited. The effects of individual bacterial species within the gut microbiota are complex and depend on factors such as their abundance, interactions with other microbes, and the overall composition of the gut microbiota.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 1.63 | 10 | 7000 | 0 | 3807 | 910.8 | 187 | 1477.7 | 0 | 1645 | 0 %ile | 100 %ile | ||
thorne | 100 | 23 | 1071 | 0 | 741 | 267.9 | 185 | 241.4 | 23 | 587 | 0 %ile | 100 %ile | ||
thryve | 34.39 | 0 | 19 | 16 | 136 | 0 | 709 | 132.6 | 34 | 293.8 | 8 | 166 | 8 %ile | 92 %ile |
ubiome | 14.58 | 0 | 21 | 18 | 1468 | 0 | 617 | 146.6 | 69 | 240.2 | 3 | 209 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 114.44 | 436.72 | 0.0114 | 0.0437 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSightRdp | 9.375 % | 0.003 % | 0.002 % | 3.0 | 32 |
bugspeak | 100 % | 0.007 % | % | 1.0 | 1 |
CosmosId | 9.375 % | 0.004 % | 0.005 % | 3.0 | 32 |
custom | 22.034 % | 0.104 % | 0.182 % | 13.0 | 59 |
es-xenogene | 72.414 % | 0.119 % | 0.124 % | 21.0 | 29 |
Medivere | 100 % | 0.056 % | 0.086 % | 7.0 | 7 |
Thorne | 84.27 % | 0.015 % | 0.019 % | 75.0 | 89 |
Thryve | 33.116 % | 0.014 % | 0.029 % | 458.0 | 1383 |
uBiome | 14.52 % | 0.015 % | 0.024 % | 115.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.